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Activation of mucosal immunity is a key milestone for next-generation vaccine devel-
opment. Biocompatible polymer-based nanoparticles (NPs) are promising vectors and 
adjuvants for mucosal vaccination. However, their in vivo uptake by mucosae and their 
biodistribution in antigen-presenting cells (APCs) need to be better understood to opti-
mize mucosal nanovaccine designs. Here, we assessed if APCs are efficiently targeted in 
a spontaneous manner by surfactant-free poly(lactic acid) nanoparticles (PLA-NPs) after 
mucosal administration. Combining histology and flow imaging approaches, we describe 
and quantify the mucosal uptake of 200 nm PLA-NPs in adult zebrafish. Following bath 
administration, PLA-NPs penetrated and crossed epithelial barriers from all exposed 
mucosae. In mucosae, PLA-NPs accumulated in APCs, which were identified as den-
dritic cells (DCs), macrophages, and IgZ+ B cells in gills and skin. PLA-NP uptake by 
phagocytes was specific to these cell types, as PLA-NPs were not detected in neutro-
phils. Importantly, quantitative analyses in gills revealed that DCs take up PLA-NPs with 
specifically high efficiency. This study shows that surfactant-free PLA-NPs, which display 
optimal biocompatibility, can spontaneously target DCs with high efficiency in vivo follow-
ing mucosal administration, and highlights PLA-NPs as powerful platforms for mucosal 
vaccine delivery in the medical and veterinary fields, and particularly in aquaculture.
Keywords: poly(d,l-lactic acid) nanoparticles, surfactant free, zebrafish, vaccines carrier, mucosal delivery, 
dendritic cells, imaging flow cytometry, biodistribution
inTrODUcTiOn
Mucosae represent the first defensive barriers of the organism against most pathogens. Their defenses 
rely not only on physical barriers such as mucus production and mono- or multi-layered epithelia 
but also on specific immune systems called mucosa-associated lymphoid tissues (MALTs). The local 
activation of MALTs is currently a major challenge in vaccinology, both for human and veterinary 
medicine (1–3). In the fish farming industry, mucosal vaccines raise a growing interest compared to 
injected ones, as they offer wider possibilities for immunizing young fish, are easier to administer 
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to large animal numbers, and cause less stress and tissue damage 
(4). As soluble antigens are poor mucosal immune inducers by 
themselves, extensive efforts have been made to develop par-
ticulate vaccine carriers able to cross the mucus and epithelial 
layers constituting mucosal barriers and deliver antigens to the 
key initiators of immune response, the antigen-presenting cells 
(APCs) (2, 3).
Some of the most promising vaccine vehicles for mucosal 
delivery are biodegradable polymeric nanoparticles (NPs), 
in particular NPs based on poly(d,l-lactic acid) (PLA) and its 
copolymer poly(lactic acid co-glycolic acid) (PLGA) (5, 6). PLA 
and PLGA are Food and Drug Administration-approved bio-
compatible lactate-based polyesters, which present high safety 
records, can be completely resorbed in the body by metaboliza-
tion of their degradation products, are easy to produce and are 
eco-compatible (7). PLA- and PLGA-NPs constitute versatile 
vectors for adsorbing and/or encapsulating antigenic peptides 
and immunostimulant drugs (8, 9). They have been shown to 
induce immune responses against various model antigens follow-
ing parenteral administration in mammals (2, 8). Their mucosal 
administration has also revealed their ability to cross mucosal 
barriers, reach some APCs, and elicit mucosal immune responses 
(6, 10–12). In fish, submicron PLGA particles have shown 
encouraging effects of immune response enhancement, follow-
ing administration by injection and oral routes (9). However, a 
detailed understanding of in vivo uptake and biodistribution of 
polymeric NPs following mucosal administration is still lacking, 
which has limited their development as mucosal vaccine vehicles 
in vertebrates, and more particularly in fish. Here, we analyze if 
polymeric NPs efficiently cross fish mucosal barriers and reach 
APCs in vivo, using surfactant-free 200 nm poly(lactic acid) nano-
particles (PLA-NPs) as a model. PLA-NPs were prepared without 
any surfactant, for optimal biocompatibility (13). Because NPs 
generally become quickly coated by proteins and factors present 
in biological media (14), this model is likely representative of a 
variety of NPs which surface is functionalized using targeting or 
antigenic proteins.
We performed this study in adult zebrafish (Danio rerio), a 
teleost fish model well suited for analyzing whole-body biodis-
tribution with a cellular level of resolution, and benefiting from a 
rising number of available transgenic lines and molecular mark-
ers of immune cell types (15–17). The major lymphoid organs of 
teleosts are the kidney marrow, which is the site of hematopoiesis, 
the thymus and the spleen (18). Like other teleosts, zebrafish lack 
lymph nodes and display a diffuse lymphoid tissue organization 
in mucosae (4, 19). Zebrafish adaptive immune system becomes 
fully competent at juvenile stage (15, 20). They have three classes 
of immunoglobulins, M, D, and Z (called T in other teleosts), 
IgZ/T being the functional equivalent of mammalian mucosal 
IgA (21). Professional APCs such as macrophages, dendritic cells 
(DCs), and B cells have all been identified in zebrafish. Although 
it was in teleosts that the phagocytic ability of B cells was first 
recognized, it is still unclear if fish APCs fulfill similar roles 
to their mammalian counterparts in the initiation of adaptive 
immune responses (22, 23). Yet, DC cells capable of phagocy-
tosis and T-cell stimulation were identified in zebrafish kidney 
marrow, and conserved co-stimulatory molecules (CD80/CD86 
and CD83) have been detected in T-cell stimulating cells, further 
supporting a conservation of DC function in fish (24–26).
Main mucosae of adult teleosts are found in the gut, gills, 
skin, and nose; their MALTs are accordingly sub-divided into 
gut-, gill-, skin-, and nose-associated lymphoid tissues (GALT, 
GIALT, SALT, and NALT, respectively) (19, 21). Most leuko-
cyte types are present in fish MALTs, including phagocytes 
(neutrophils, macrophages, DCs, and B cells), T cells, and 
plasma cells.
Here, we analyzed the biodistribution of PLA-NPs admin-
istered to adult zebrafish by immersion, a straightforward 
administration method targeting gut, gills, skin, and nasal 
mucosae altogether. We show that in vivo, surfactant-free PLA-
NPs naturally penetrate and cross the mucosal epithelial barriers 
with high efficiency and are specifically accumulated in mucosal 
APCs, and not in neutrophils. Quantification in the gills reveals 
that DCs are the major APC type taking up PLA-NPs, with up to 
65% being detected as positive for NPs. Our results suggest that 
active targeting strategies are not necessarily required for efficient 
uptake of polymeric NPs by mucosal DCs, and further highlight 
the potential of PLGA- and PLA-NPs as mucosal vaccine vehicles 
for applications in aquaculture.
MaTerials anD MeThODs
nP Preparation and characterization
Poly(lactic acid) nanoparticles were produced as previously 
described (10, 27). The red CellTrace BODIPY TR Methyl Ester 
(™) or green BODIPY 500/510 C4, C9 (™) fluorophores (Life 
Technologies) were encapsulated using a fluorophore:PLA 
ratio of 0.04% w/w. The NP size and size polydispersity were 
determined by diffuse light scattering using a Zetasizer nanoS 
apparatus (Malvern Instrument, UK).
Fish stocks, nP administration, and ethic 
statement
Experiments were performed on wild-type AB/Tubingen zebrafish 
and transgenic Tg(mhc2dab:GFP)sd6 (25), Tg(mpeg1:mCherry)
gl23 (28), Tg(mpx:GFP)i114 (29), and Tg(fli1:GFP)y1 (30) lines. 
Adults were individually immersed for 24 h at 28°C in 100 mL 
of fresh fish facility water, containing 0.01 or 0.05% fluorescent 
PLA-NPs. The experiments were conducted in accordance with 
the animal care guidelines of the European Union and French 
law, and the protocols were approved by the local Animal 
Ethic Evaluation Committee (No. CE015: Comité d’Evaluation 
Commun au Centre Léon Bérard, à l’Animalerie de transit de 
l’ENS, au PBES et au laboratoire P4—CECCAPP).
histology
Animals exposed to red NPs were euthanized by tricaine overdose, 
fixed in 4% PFA for 24 h at 4°C, then immersed in 30% sucrose 
for several days, embedded in Tissue-Tek O.C.T. Compound 
(Sakura Finetek USA), flash frozen in isopentane, and sectioned 
using a CM3050 S cryostat (Leica). DCs were stained using 1:50 
FITC conjugate peanut agglutinin (FITC-PNA) (US Biological). 
Macrophage, neutrophil, and IgZ+ were stained using 1:250 rabbit 
TaBle 1 | nanoparticle (nP) characteristics.
nP Fluorophore Mean diameter (nm) Polydispersity 
index
Red fluorescent—
poly(d,l-lactic 
acid) (PLA)
CellTrace BODIPY 
TR methyl ester
225.4 ± 4.6 0.04 ± 0.01
Green 
fluorescent—PLA
BODIPY 500/510 
C4, C9
199.9 ± 2.5 0.05 ± 0.01
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anti-Mpeg1, 1:50 rabbit anti-Mpx, and 1:500 rabbit anti-IgZ-IN2 
antibodies (AnaSpec), respectively, and 1:250 cross-adsorbed 
goat anti-rabbit secondary antibody (Thermo Fisher), which 
were either conjugated to DyLight 488 (for IgZ staining) or to 
DyLight 633 (for Mpx and Mpeg1 stainings). For double staining, 
cryosections were saturated with 5% BSA between FITC-PNA 
and antibody labeling. No cross staining was observed for PNA/
IgZ labeling, while a weak PNA signal could be detected in a few 
Mpeg1+ macrophages. Mpx+ neutrophils consistently displayed 
moderate PNA signal, but distinct from DCs, which displayed 
high granular intracytoplasmic PNA staining and were Mpx−. 
Cryosections were co-stained with DyLight 488-Phalloidin 
(Thermo Fisher) and DAPI (Euromedex) and analyzed using a 
SP5 upward confocal microscope (Leica) with 63×/1.4NA objec-
tive and ImageJ.
Flow cytometry
The organs from euthanized animals (exposed to red PLA-NPs) 
were collected in cold PBS/heparin (1  U/mL)/FBS (2%). Cell 
suspensions from brain, gill, liver, spleen, and kidney were 
directly homogenized by passing through a 40-μm mesh filter 
(Fisherbrand). Skin and gut samples were dissociated for 8 min 
in 0.2% porcine trypsin (Sigma-Aldrich) in Versene solution 
(Life Technologies) before mesh filtration. Washed cell suspen-
sions were treated with DAPI (2.5 μg/mL) to mark dead cells and 
processed using a LSRII Flow Cytometer (BD Biosciences). Data 
were analyzed using FlowJo v7.6.5.
imaging Flow cytometry for internalization 
score
Cell suspensions, prepared as described above, were stained 
with 1:500 CellMask Green Plasma Membrane Stain (Life 
Technologies), treated with DAPI (10  μg/mL), and analyzed 
using an ImageStreamX Mark II imaging flow cytometer (Amnis, 
Millipore) with 63× objective, and IDEAs software. Cells with NP 
signal peaking at least sevenfolds over background were selected, 
and their cytoplasmic area (excluding membrane) was automati-
cally determined based on CellMask signal. The internalization 
score, reflecting the ratio of cytoplasmic to total brightness inten-
sity, was computed for each cell using a built-in IDEAS function. 
As a negative control for NP internalization, cell suspensions 
from unexposed fish were incubated with 0.002% red NPs for 
30 min at 4°C.
imaging Flow cytometry for Quantification 
of nP Uptake
For macrophages and neutrophils identification, cell suspen-
sions were prepared from gills of Tg(mpeg1:mCherry)gl23 or 
Tg(mpx:GFP)i114 adults exposed to 0.05% green or red NPs 
(respectively); dead cells were marked using DAPI. For DC and 
IgZ+ cell staining, cell suspensions were prepared from gills of 
wild-type zebrafish exposed to red NPs, marked using 1:1,000 
LIVE/DEAD Fixable Violet Dead Cell Stain Kit (Thermo Fisher) 
and fixed/permeabilized using 2% PFA/0.1% triton X-100. DCs 
were stained using 1:2,000 FITC-PNA in absence of FBS. IgZ+ cells 
were stained using 1:2,000 rabbit anti-IgZ (AnaSpec) and 1:2,000 
DyLight488 conjugate cross-adsorbed goat anti-rabbit antibodies 
(Thermo Fisher). Samples were analyzed using ImageStreamX 
(50,000–100,000 events per acquisition) and IDEAS software. For 
DCs gating, events displaying the highest level of PNA staining 
were selected, from which cells devoid of an intracellular PNA 
signal or presenting a thick capsid (a hallmark of rodlet cells) 
were excluded.
statistical analysis
Statistical analyses were performed using GraphPad Prism 6. 
Normality of samples was tested using Agostino and Pearson 
omnibus normality test. For flow cytometry experiments, one-
way ANOVA coupled with Bonferroni multiple comparison 
post  hoc analysis was carried on populations that passed the 
normality test (gills, skin, and kidneys). On populations that 
failed the normality assay (liver), the non-parametric equivalent 
Kruskal–Wallis test with Dunn’s multiple comparison post  hoc 
analysis was used. For flow imaging experiments, as none of the 
populations respected the normality, a one-sided Mann–Whitney 
test was performed. Significance level is indicated as *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001.
resUlTs
Pla-nP characterization
Poly(lactic acid) nanoparticles were produced by nanopre-
cipitation, a single step process whereby acetone-dissolved PLA 
is precipitated into a swirling aqueous phase of water and ethanol, 
in absence of surfactant. To detect PLA-NP by fluorescence imag-
ing, red or green fluorescent dyes were encapsulated in NPs, by 
mixing the dyes with acetone. For optimal NP biocompatibility, 
water and acetone solvents were evaporated in the final product 
to a residual concentration well below 5,000 ppm, in accordance 
with European pharmacopeia standards. Red and green PLA-NPs 
displayed mean diameters of 225 and 200 nm, respectively, and 
were highly homogeneous in size within a batch, as shown by 
scanning electron microscopy and by diffuse light scattering 
indicating a low polydispersity index (Table  1; Figure S1 in 
Supplementary Material). Fluorophore-loaded PLA-NPs had a 
typical zeta potential of −60 mV.
Pla nPs are Taken Up by epithelial cells 
of all Targeted Mucosae
To study the mucosal uptake of PLA-NPs in vivo, we immerged 
zebrafish for 24  h in a bath containing 0.01% red NPs. This 
administration method targets gills, skin, nasal mucosa, and 
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gut altogether and involves minimal manipulation that could 
be stressful to the fish or damaging to the tissues; indeed, the 
treatment did not cause more detectable stress than the transient 
increase of opercular breathing rhythm typically caused by 
netting and transfer of the fish from one tank to another. To 
determine PLA-NP biodistribution at whole-body level, NP 
localization was first analyzed by histological approaches, using 
confocal imaging of 40-μm-thick longitudinal whole-body 
cryosections. Images were taken within the core of cryosections, 
which allowed us to avoid the top and bottom edges of cryosec-
tions where we observed artifactual displacement of PLA-NPs 
related to cryosectioning and slide immersion (Figure S2 in 
Supplementary Material).
We first investigated if PLA-NPs were taken up by epithelial 
cells of mucosae primarily exposed to NPs. In all these tis-
sues, NPs were found in epithelial cells bordering the external 
environment (Figure  1). The gills, which have a gas-exchange 
function, typically display an extremely branched architecture 
of primary lamellae supporting secondary lamellae, which each 
consist in a network of capillaries sustained by endothelial pillar 
cells and covered by a non-keratinized squamous epithelium. 
PLA-NPs were detected in the epithelium lining the branchial 
cavity, and more specifically in pavements cells, identified by 
their typical actin microridges (Figure 1A). Located just below 
the gill cavity epithelium, the fish thymus may also be primarily 
exposed to NPs upon immersion administration (31). Indeed, 
we detected NPs in the outermost layer of pharyngeal epithelial 
cells covering the thymus (Figure 1B). The fish skin, unlike in 
mammals, is considered a mucosa: its outermost layer is made 
of living and proliferating cells coated with mucus and mucosal 
IgZ/T antibodies (32). The epithelial cells form a stratified non-
keratinized epidermis, interspersed with pores located over 
various types of mucus-secretory cells. We detected PLA-NPs 
both in keratinocytes and in goblet cells (Figure  1C). As in 
mammals, the fish gut displays a single epithelial layer mainly 
composed of brush-bordered enterocytes and mucus-producing 
goblet cells, supported by folds of connective lamina propria (33). 
We detected PLA-NPs in enterocytes throughout the intestine 
(Figures 1D–E), with a particularity in the post-midgut, where 
a high concentration of NPs was observed in supranuclear vacu-
oles of so-called specialized enterocytes, which were described 
as a functional equivalent of the antigen-sampling mammalian 
M-cells (34, 35) (Figure  1E). NPs were also observed in the 
nasal mucosa, in cells of the ciliated pseudostratified columnar 
epithelium (Figure  1F). Thus, despite the mucus layer cover-
ing mucosal epithelia, PLA-NPs reached and were taken up by 
epithelial cells of all exposed mucosae.
Pla nPs cross Mucosal epithelial Barriers 
and reach Mucosal aPcs
We then analyzed if PLA-NPs were able to cross epithelial bar-
riers to reach mucosal APCs, in cryosections. We detected NP 
accumulations in cells located in the deeper layers of the skin and 
the gills, in the lamina propria of the gut, in the lympho-reticular 
parenchyma of the thymus and in the nasal lamina (Figure 1). In 
the post-midgut, NPs were also found translocated at the basal 
boundaries of specialized enterocytes (Figure 1D). A variety of 
leukocytes, including phagocytes, are present in deep epithelial 
and sub-epithelial areas (19). The pattern of NP accumulations 
suggested that these NP-positive cells could be phagocytes.
To identify these cells, we labeled gills and skin cryosections 
using specific markers, such as Mpx and Mpeg1, expressed in 
neutrophils and macrophages, respectively (28, 29). IgZ stain-
ing was used to identify cells of the B-cell lineage specialized in 
mucosae protection, as described in trout (36). The identification 
of DCs was performed based on their affinity for PNA, a surface 
marker of live DCs (24). In fixed, permeabilized cryosections, 
cells with the highest PNA+ signal exhibited a granular intracy-
toplasmic staining and cellular protrusions reminiscent of den-
drites. They displayed a strong MHC class 2 staining in transgenic 
mhc2dab:EGFP fish (Figure S3 in Supplementary Material) and 
were negative for Mpeg1 and IgZ stainings (Figure  2), further 
suggesting that these are DCs.
Following PLA-NP exposure, DCs displayed a strong uptake 
of NPs in gills (Figures 2A,B), as well as in skin (Figure 2D). In 
gills, PLA-NPs were also observed in a number of macrophages 
(Figure  2B) and less frequently in IgZ+ cells (Figure  2C). 
Interestingly, no NPs were detected in neutrophils (Figure 2A).
Pla nPs enter the Bloodstream
In addition to their accumulation in APCs, we detected scattered 
PLA-NPs in the circulatory system, as seen in blood vessels of 
the primary lamellae in gills (Figure 1A). Immersion exposure 
of transgenic fli:GFP adult zebrafish to fluorescent NPs at higher 
concentrations (0.05%) revealed not only numerous PLA-NPs 
in the gill bloodstream (Figure 3) but also NP internalization in 
endothelial cells (Figures 3B,B’). Thus, PLA-NPs cross mucosae 
and enter the bloodstream, suggesting that NPs may also reach 
internal organs.
Indeed, NP accumulations were observed in liver cells close 
to sinusoids (Figure 3C). These cells, which displayed an oblong 
nucleus distinct from the round shaped nucleus with scattered 
chromatin of hepatocytes, may correspond to macrophages or 
hepatic stellate (Ito) cells (37, 38). NPs were never detected in 
brain, spleen, or kidney cryosections.
Pla nPs Penetrate the Organism in a 
Dose-Dependent Manner and reach liver 
and Kidney
To quantify the PLA-NP uptake in primary and secondary 
exposure organs, we performed flow cytometry on dissociated 
cells of various candidate organs, which were dissected from fish 
exposed for 24 h to 0.01 or 0.05% fluorescent NPs by immersion 
(Figures  4A–C). Consistent with confocal observations, gills 
and skin displayed 0.86 and 0.65% NP-positive cells, respec-
tively, following 0.01% NP exposure. A dose-dependent uptake 
was observed in these organs, among which the proportion of 
NP-positive cells tripled (2.5 and 2.1%, respectively), for 0.05% 
NP exposure. Quantification of NP uptake by this approach was, 
however, not applicable to intestines, due to the large number 
of debris corresponding to mucus and intestinal content loaded 
with NPs (not shown).
FigUre 1 | Biodistribution of poly(lactic acid) nanoparticles (Pla-nPs) in mucosae and thymus. Representative confocal images of gills (a), thymus (B), 
skin (c), intestines (D,e), and the olfactory mucosa (F), of wild-type adults immersed for 24 h in 0.01% red fluorescent nanoparticles (NPs). Images were acquired in 
40-μm-thick whole-body cryosections, stained with phalloidin (green) and DAPI (blue). (a) In gills, NPs are found in pavement cells lining the branchial cavity 
(arrowheads), accumulated in cells located in the sub-epithelial compartment (stars), and detected in the blood (arrow). (B) NPs are located in pavement cells lining 
the branchial cavity above the thymus (arrowheads) and accumulated in cells of the lympho-reticular parenchyma in the thymus (stars). (c) In skin, NPs are visible in 
keratinocytes (arrowhead), goblet cells (characterized by kidney-shaped nucleus, arrow) and accumulated in intra-epithelial cells (star). (D,e) In the intestine, a high 
number of NPs is found inside the intestinal lumen (D). As illustrated in the end-gut (D), NPs are taken up by enterocytes (arrowheads), which display a diffuse 
signal. A number of NPs is also observed in sub-epithelial cells (stars). In the post-midgut (e), NPs are mainly found in apical areas of specialized enterocytes 
(arrowheads); a subset is also found at the basal epithelial side (arrows). (F) In the nasal mucosa, NP-positive cells are found in the olfactory epithelium (arrowhead) 
and the lamina (arrows). NPs are accumulated in large cells of the lamina (stars). B, blood vessels; pL, primary lamellae; sL, secondary lamellae; Bc, branchial cavity; 
Rc, rodlet cells; E, epidermis; D, dermis; Ext, external environment; Lu, Lumen; Ep, epithelium; Lp, lamina propria; Sm, smooth muscles; Lrp, lympho-reticular 
parenchyma; La, lamina. Scale bar: 10 μm (B,e), 20 μm (a,c,F), and 30 μm (D).
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Regarding internal organs, flow cytometry analysis cor-
roborated the absence of NP uptake in the brain and the spleen 
observed by histology approaches. In kidney, however, a small 
population of NP-positive cells was detected by flow cytometry, 
increasing with NP concentration, but reaching only 0.16% at 
the highest NP concentration (Figure 4C). Consistent with his-
tological observations, a higher mean of 3.5% positive cells was 
detected by flow cytometry in the liver for 0.01% NP exposure. 
Contrary to other organs, the proportion of liver NP-positive 
cells showed no significant difference between the two PLA-NP 
FigUre 2 | Poly(lactic acid) nanoparticles (Pla-nPs) are accumulated in mucosal antigen-presenting cells. (a–D) Representative confocal images of gills 
(a–c) and skin (D) of wild-type adults immersed for 24 h in 0.01% fluorescent PLA-NPs (red). Images were acquired from 40-μm-thick whole-body cryosections, 
stained for neutrophils (Mpx-positive, cyan) (a), macrophages (Mpeg1-positive, cyan) (B), IgZ+ B-cells (green) (c), and dendritic cells (DCs) (PNA, green) (a,B,D), in 
addition to nuclei (DAPI, blue). Maximal intensity projections from 3 (a–c) or 5 (D) optic sections acquired every micrometer. Nanoparticle (NP) accumulations are 
observed in gill DCs [(a,B), arrows], macrophages [(B), star], and IgZ+ cells [(c), arrow], while no NP are detected in neutrophils [(a), stars]. NPs are also taken up 
by a network of skin DCs [(D), arrows]. pL, primary lamellae; sL, secondary lamellae; Bc, branchial cavity; B, blood; C, cartilage; Ext, external environment; E, 
epidermis. Scale bar: 10 μm.
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concentrations, suggesting that liver capacity may be reached at 
low NP concentration, as least in term of cell number.
Pla nPs are actively internalized and 
accumulate in Kidney cells with Myeloid 
cell Features
Because flow cytometry does not allow discrimination of true NP 
internalization events from cases where NPs are simply stuck on 
the plasma membrane, we performed imaging flow cytometry 
to clarify this point. Single cells isolated from fish exposed to 
0.05% PLA-NPs displayed a clear intracellular NP localization, 
as revealed by the use of a plasma membrane marker, and 
illustrated in kidney cell suspensions (Figures 5A,B). The signal 
pattern was different when cells were exposed in vitro to PLA-
NPs under conditions that block internalization (4°C), where 
NPs were seen aside cells or stuck on their plasma membrane 
(Figure  5C). This was quantified by computing internalization 
scores based on a large number of single cells (Figure  5A). 
Altogether, PLA-NP internalization score was 1,000 times higher 
for cells of NP-exposed fish, than for the 4°C control. These data 
not only validate the consistency of our previous flow cytometry 
results but also reveal that PLA-NPs are actively taken up in cells 
of primary and secondary organs, following fish immersion.
Interestingly, as for the large gill cells with NP accumulations, 
the NP-positive kidney cells displayed cellular processes reminis-
cent of dendrites (Figures 5B,D), suggesting that these might be 
myeloid cells and possibly DCs.
Dcs are the Major Mucosal aPcs Taking 
Up nPs In Vivo
The spontaneous targeting of PLA-NPs to APCs after mucosal 
administration (Figure 2) unveiled their promising potential as 
FigUre 3 | nanoparticles (nPs) reach the circulatory system and the liver. (a,B′) Representative confocal images of gills from transgenic fli:GFP adults 
bathed for 24 h in 0.05% red fluorescent NPs. Images were acquired in 40-μm-thick whole-body cryosections, stained with DAPI [blue in (a)]. NPs are found in the 
lumen of gill arch (a) and gill filament (B) blood vessels, which are delimited by green endothelial cells. NPs were also detected inside endothelial cells [arrow in (B)]. 
(B′) These observations are confirmed by the orthogonal view realized in the area between the two dotted lines in (B). (c) Representative confocal image of the liver 
of wild-type adults exposed to 0.01% red fluorescent NPs. Images were acquired in 40-μm-thick whole-body cryosections, stained with phalloidin (green) and DAPI 
(blue). NPs are highly concentrated in cells close to sinusoids (s) and displaying an oblong nucleus (arrows). pL, primary lamellae; sL, secondary lamellae; Bc, 
branchial cavity; B, blood vessel; Ga, gill arch; C, cartilage; Hp, hepatocytes. Scale bar: 10 μm (B,B′), 20 μm (a,c).
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mucosal vaccine vectors. To quantify in a robust manner their 
tropism for phagocytes, we used high-resolution flow micros-
copy on single cell suspensions from fish exposed for 24  h to 
0.05% fluorescent NPs. This was performed on gills, which are 
not only easy to dissociate, but also represent an organ of high 
significance for host-pathogen interactions, offering a wide 
area of contact with the environment (39). In these experi-
ments, specific labeling of neutrophils and macrophages was 
achieved using mpx:eGFP and mpeg1:mCherry transgenic fish, 
respectively, while DCs and IgZ+ cells were identified, based 
on previous histological results (Figure 2), as cells with strong 
granular and intracellular PNA staining, and cells with strong 
IgZ signal, respectively.
Phagocytes represented over 25% of all NP-positive cells, 
although they constitute less than 5% of total gill cells (Figure 6A). 
Of these, DCs were the most abundant NP-positive phagocytes 
(12.4% of total NP-positive cells) (Figures 6A,G). Macrophages 
and IgZ+ cells represented 9.3 and 3.8% of total NP-positive 
cells, respectively (Figures  6A,F,H). Moreover, we confirmed 
the absence of NP detection in neutrophils (Figures  6A,E). 
The 60-fold enrichment in DC proportion in NP-positive cells, 
compared to their overall proportion among total gill cells, is 
especially striking. This ratio is to be compared to the fivefold 
enrichment for macrophages and threefold enrichment for 
IgZ+ cells. This strong uptake tendency of DCs was additionally 
evidenced by NPs being detected in 65% of all DCs (Figure 6B). 
By contrast, PLA-NPs were detected in only 13.8 and 3.7% of 
macrophages and IgZ+ cells, respectively.
Poly(lactic acid) nanoparticles were not only taken up by 
many DCs but also present in large amounts in these cells. Indeed, 
relative to the average intensity detected for all NP-positive cells, 
DCs and macrophages, but not IgZ+ cells, displayed significantly 
higher signal (Figure  6C). When a “spot count” analysis was 
applied, DCs significantly displayed the highest number of 
intracellular PLA-NP spots (on average 5.9 spots/cell), compared 
to macrophages (on average 2.1 spots/cell) and IgZ+ cells (on 
average 1.9 spots/cell) (Figure 6D).
Altogether, our results demonstrate that following mucosal 
administration, surfactant-free PLA-NPs are not only spontane-
ously internalized by epithelia but also efficiently accumulated 
in mucosal APCs and especially in DCs, which likely represent 
crucial target APCs of vaccine approaches.
FigUre 4 | Quantitative analysis of poly(lactic acid) nanoparticles (Pla-nPs) uptake in primary and secondary exposure organs. (a) Flow cytometry 
analysis of nanoparticle (NP) uptake in gills, skin, kidney, liver, brain, and spleen, following exposure to 0.01 or 0.05% red fluorescent NPs. Histograms represent the 
mean percentage of positive cells for each organ. While no NP uptake was detected in brain and spleen, PLA-NPs significantly penetrated all other organs in a 
dose-dependent manner, except for the liver where no significative fluctuation was observed. (B,c) Representative biparametric representations of NP uptake in gills 
(B) and whole-kidney marrow (c). NP-positive cells are mainly found among FSC-high cells. Error bars: SEM. Significance level is indicated as: *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001. Number of fish per condition (control/0.01/0.05%): gills (9/13/9), skin (9/13/9), kidneys (12/12/12), liver (12/12/12), brain 
(6/6/6), and spleen (6/6/6).
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DiscUssiOn
An increasing body of evidence has revealed the potential of 
biodegradable polymeric NPs for mucosal immunization, in the 
medical and veterinary fields, and in particular in aquaculture, 
where oral, dipping, and balneation methods of administration 
are more convenient and less damaging than injection. Yet, 
designing strategies to further enhance efficacy of polymeric 
NPs as mucosal vaccine vehicles requires a better understand-
ing of how they are taken up by mucosae and get distributed 
in the organism, an aspect that has been often overlooked in 
the field at the expense of functional immunization studies. 
Here, using 200  nm PLA-NPs as model NPs administered to 
adult zebrafish, we analyzed if surfactant-free polymeric NPs 
are efficiently naturally taken up by mucosae and to what extent 
they reach DCs, which in mammals are key professional APCs 
leading the immune response. Zebrafish were immersed for 24 h 
in a bath of fluorophore-loaded PLA-NPs, a simple administra-
tion mode that altogether targets mucosae in gills, gut, skin, 
and nasal cavities. Using an unbiased histological approach at 
whole-body level, combined to quantification by flow cytometry 
and advanced flow imaging in dissected organs, we showed that 
PLA-NPs crossed mucosal barriers of all analyzed mucosae and 
accumulated with specifically high efficiency in mucosal APCs, 
in particular in DCs. As surfactant-free PLA-NPs are most likely 
quickly covered by factors present in immersion water and bio-
logical tissues (14), the biodistribution of non-functionalized 
PLA-NPs that we describe here may also be indicative of the 
general tropism of surfactant-free polymeric NPs, functional-
ized or not.
surfactant-Free Pla-nPs efficiently cross 
Mucosal Barriers
At the mucosal level, we observed a conserved pattern whereby 
PLA-NPs penetrated cells of the outer epithelial layer and 
accumulated in phagocytes of deeper layers (Figures  1 and 
4). PLA-NPs were detected in pavement epithelial cells and 
phagocytes of gills, skin, and nose, in accordance with previous 
studies that examined the uptake of microspheres, bacteria, or 
nanoliposomes, in trout and zebrafish (40–43). PLA-NPs were 
also found in the epithelium and phagocytes of the nasal mucosa, 
which constitutes a promising site for mucosal vaccination in 
fish and mammals (44, 45). Furthermore, PLA-NPs swallowed 
during immersion (46) were very efficiently taken up by entero-
cytes, which displayed strong and diffuse NP signals in most gut 
regions, and were detected in phagocytes of the lamina propria, in 
agreement with other studies that addressed the intestinal uptake 
of bacteria, submicron polymeric NPs or proteins (34, 47). High 
amounts of PLA-NPs were also detected in supranuclear vacuoles 
of post-midgut specialized enterocytes. These cells were shown 
to take up foreign material such as proteins, gold NPs or bac-
teria from the gut lumen, and store it in supranuclear vacuoles, 
and were suggested to play an antigen-sampling role similar to 
mammalian M-cells (34, 35, 43, 47). Supporting this notion, 
we detected accumulations of PLA-NPs at the basal side of the 
specialized enterocyte epithelium (Figure  1D). Although we 
cannot rule out that PLA-NP sampling is directly performed in 
the lumen by phagocytes themselves, these observations confirm 
that highly efficient antigen uptake takes place in the post-midgut 
region.
FigUre 5 | active nanoparticles (nPs) internalization in cells of mucosae, kidneys, and liver. (a) NP internalization score, assessed by imaging in flow, in 
dissected organs from adult zebrafish exposed to 0.05% red fluorescent NPs (red histograms). As a negative control for internalization (blue histograms), PLA-NPs 
were added at 4°C just before acquisition on the cell suspension from fish unexposed to NP. Whereas most NPs are found at or outside the cell membrane in the 
negative controls (internalization scores <−1), a high majority of NPs is detected inside the cells of NP-treated fish (internalization scores >2) in all analyzed organs. 
(B–D) Representative images of NPs in kidney (B,c) or gill (D) cell suspensions, from NP-exposed fish (B,D) or control conditions (c), which display membrane 
processes reminiscent of dendrites. Total number of analyzed cells (NP 0.05%/4°C control): gills (three independent acquisitions) 1312/4355, skin (two independent 
acquisitions) 345/4185, liver (two independent acquisitions) 1431/2651, and kidney (one acquisition) 117/3180. One fish per acquisition. Error bars: SD.
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Thus, PLA-NPs efficiently cross epithelial barriers of all 
exposed mucosae. The fate of NPs taken up by mucosal epithelial 
cells and phagocytes, and the path taken by NPs from mucosal 
surfaces to the blood vessels remain to be investigated, to deter-
mine to what extent phagocytes contribute to this transport and 
if other transport mechanisms occur in mucosae.
surfactant-Free Pla-nPs reach a subset 
of Organs with immune-related Functions
Being positioned in the gill cavities, the thymus, which is the 
primary lymphoid organ for T lymphocytes development (31), 
seems primarily exposed to foreign antigens. As in mucosae, 
PLA-NPs were detected in the outer layer of epithelial cells 
covering the thymus and accumulated in cells of deeper layers, 
suggesting an intriguing role of the thymus as antigen-sampling 
organ. This paradox, for an organ that plays a key role in self-non-
self discrimination, deserves further study.
We furthermore demonstrated that PLA-NPs reach a subset 
of internal organs. The accumulation pattern of NPs in liver 
cells morphologically distinct from hepatocytes suggests that 
these cells may be macrophages or hepatic stellate cells, which 
in mammals not only have the ability to engulf NPs but were 
also described as liver-resident professional APCs able to induce 
potent immune responses (37, 38, 48). The possibility that liver 
NP-accumulating cells may be APCs remains to be explored. We 
also identified by flow cytometry the presence of a small amount 
of PLA-NP-positive cells in kidney, which in teleosts is the main 
primary lymphoid organ and a site for antigen presentation and 
lymphocyte maturation, as well as the niche for antibody produc-
ing cells (49). Imaging flow cytometry on isolated kidney cells 
revealed the presence of NP-accumulating cells with processes 
reminiscent of dendrites, suggesting that NPs might be present 
in DCs in this organ. The functional importance of NP presence 
in thymus, liver, and kidneys for immune response remains to 
be further investigated. In the spleen, confocal microscopy and 
flow cytometry did not reveal any PLA-NP signal above the 
high intrinsic fluorescence. While PLGA-NPs accumulate in the 
spleen shortly after being administered by gavage, polystyrene 
beads do not (47). Moreover, Yersinia antigens were detected 
in the spleen after immersion administration, but not 125 nm 
FigUre 6 | continued
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nanoliposomes (43, 50). Size difference, administration method, 
and NP composition may strongly influence particulate carrier 
uptake by the spleen.
The presence of PLA-NPs in spleen and kidney raises ques-
tions regarding the path taken by NPs to reach internal organs. 
Although we cannot exclude that PLA-NPs diffuse through the 
mesenchymal tissue, their detection in gill blood vessels strongly 
suggests that PLA-NPs were transported to liver and kidney by 
the bloodstream. PLA-NPs, which have a hydrodynamic diam-
eter too large to undergo glomerular clearance (51), may travel 
freely in the bloodstream or may be transported by APCs.
Altogether, the ability of PLA-NPs to penetrate and accumu-
late in all mucosae and lymphoid organs, with the exception of 
the spleen, is promising for fish mucosal vaccine development. 
Moreover, the absence of PLA-NP detection in the brain by 
flow cytometry suggests that PLA-NPs were not able to cross 
the blood–brain barrier, reducing safety concerns for vaccine 
delivery.
surfactant-Free Pla-nPs efficiently Target 
Dcs and Other aPcs
Poly(lactic acid) nanoparticles accumulations were observed in 
mucosal phagocytes, corresponding to the three professional 
classes of APCs: macrophages, B cells, and DCs. Surprisingly, 
we did not observe PLA-NP uptake in zebrafish neutrophils, 
which contrasts with reports of PLA-NP uptake by circulating 
neutrophils following intravascular injections in guinea pigs 
or by rat granulocytes in vitro (52, 53). This difference may be 
explained by variations in NP physicochemical characteristics, 
such as the amount of surfactant, as polyvinyl alcohol was used 
for the preparation of the PLA-NPs described in these reports 
FigUre 6 | continued  
high uptake of poly(lactic acid) nanoparticles (Pla-nPs) by mucosal dendritic cells (Dcs). (a–D) Quantification by imaging flow cytometry of the 
nanoparticle (NP) uptake by gill phagocytes from adult zebrafish, previously immersed for 24 h in 0.05% NPs. For each cell type, results from at least three 
independent acquisitions are represented as dots; histograms indicate the mean. Neutrophils and macrophages were labeled by GFP and mCherry expression in 
transgenic mpx:GFP and mpeg1:mCherry fish, respectively (one fish per acquisition). DCs and IgZ+ B-cells were identified based on high intracellular and granular 
FITC-PNA staining and intracellular IgZ staining, respectively (two fishes per acquisition). (a) Percentage of NP-positive cells, for each phagocyte type, relative to the 
total number of cells (left) or of NP-positive cells (right). APCs, which represent less than 4% of total cells in gills, represent over 25% of NP-positive cells altogether, 
among which DCs show the most important enrichment. (B) Percentage of NP-positive cells within each cell type. A high majority of DCs are positive to PLA-NPs. 
(c) NP signal intensity per cell relative to the mean fluorescence of all NP-positive cells. DCs and macrophages internalize more NPs than average. (D) NP signal 
spot count per cell. DCs display more signal foci than average. (e–h) Representative images of neutrophils (e), NP-positive macrophages (F), DCs (g), and IgZ+ 
cells (h). Error bars: SD. Significance level is indicated as: *p < 0.05, **p < 0.01.
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(52, 53). Although we cannot exclude that PLA-NPs are taken 
up by neutrophils with a different kinetics than in other APCs, 
this hypothesis is unlikely, because fish exposure to NPs was 
continuous in this protocol. One may also speculate that neutro-
phils need to be activated (e.g., by local danger signals associated 
with the injection) to become able to engulf NPs, but they did 
not in zebrafish larvae injected with PLA-NPs (unpublished 
observations).
Instead, we detected NP accumulations in mucosal APCs, 
which, after 24 h of cumulative exposure to PLA-NPs, represented 
in gills 25% of all NP-positive cells. Of these NP-positive APCs, 
half were macrophages or B cells. The initial dogma that B cells 
were incapable of phagocytosis in vivo was broken by the finding 
that teleost B cells are able to engulf and kill pathogens (54). Our 
results showing that PLA-NPs are taken up by gill IgZ+ cells sup-
port the phagocytic nature of zebrafish B cells, in agreement with 
other studies (20, 25). The macrophages function as cleaners of 
the organism, performing rapid phagocytosis, and neutralization 
of encountered foreign materials and debris. Less potent than 
DCs, they are nevertheless also involved in immune response 
triggering. Given the great representation of macrophages and 
B cells in mucosae (2 and 1%, respectively, in gills), the ability 
of these APCs to take up PLA-NPs represents an interesting 
prospect for the use of particulate NPs in mucosal vaccines.
A major part of NP-positive mucosal APCs, which represented 
over 10% of all NP-positive cells in gills, were DCs characterized 
by the following features: high intracellular and granular PNA 
staining (in fixed/permealized tissues), dentritic-like morphology, 
MHC2 expression, and absence of both Mpeg1 and Mpx expres-
sion. Although we cannot dismiss that all DCs might not share 
these characteristics, DC quantification in gills was in accordance 
with the macrophage/dendritic cell ratio previously described 
(25). In gills, where DCs represent only a small population of total 
cells, over 65% of DCs were positive to PLA-NPs and displayed 
the highest PLA-NP accumulations of all APCs, showing the great 
efficiency of DCs for PLA-NP uptake. Having unique ability to 
efficiently prime naïve T cells, mammalian DCs play a key role 
in orchestrating the activation and modulation of the adaptive 
immune response. DCs thus represent a crucial target for the devel-
opment of mucosal vaccines, and the high efficiency of PLA-NP 
uptake by mucosal DCs, in absence of targeting molecules, makes 
PLA-NPs vehicles of choice for mucosal vaccine delivery.
cOnclUsiOn
Altogether, we show that, in absence of functionalization, 
surfactant-free polymeric NPs of 200  nm are able to cross 
mucous layers and mucosal epithelia, and to be efficiently taken 
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up by DCs. Thus, balneation in polymeric NPs may represent 
a convenient and efficient way to deliver vaccine principles to 
batches of adult and young fish in the aquaculture industry. 
Although the teleost lymphoid tissues are diffuse, zebrafish 
mucosae share many structural and functional similarities with 
mammalian mucosae, suggesting that the efficient targeting of 
DCs by mucosally applied polymeric NPs may be general among 
vertebrates, with potential applications in human health. Further 
work will be needed to investigate the ability of antigen-carrying 
polymeric NPs to induce efficient immune responses by mucosal 
routes. For this, functionalization strategies designed for improv-
ing the targeting per se of NPs toward DCs may be less beneficial 
for vaccine efficiency than other strategies aimed at activating 
DCs. Altogether, thanks to their versatility for carrying immune-
stimulating molecules and antigens, their biodegradability, their 
eco-compatibility, and, as we show here, their inherent APC 
targeting ability, polymeric NPs using PLA backbone, represent 
great prospects for the enhancement of mucosal vaccines, with 
potential application in human health and aquaculture.
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